Rezvilutamide
Rezvilutamide (SHR3680) is an orally available androgen receptor inhibitor that crosses the blood-brain barrier and has antitumor activity.Rezvilutamide (SHR3680) is used in the study of metastatic desmoplasia-resistant prostate cancer.
Product Specifications
CAS Number
1572045-62-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
479.47
Molecular Formula
C22H20F3N3O4S
Notes
Research use only, not for human use.
Receptor
Androgen Receptor
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7055695 Inquire
Recombinant Synechococcus sp. ATP synthase subunit a (atpB), partial
Sign In for Pricing
View Details 
K7331706 1.0 µg DNA
Olr1414 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)
Sign In for Pricing
View Details GTR15238426 1 Vial
Lentiviral mouse Gm6583 shRNA (UAS) - Lentiviral mouse Gm6583 shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details MBS6222074-01 0.1 mL
EVI1 (MDS1 and EVI1 Complex Locus Protein EVI1, Ecotropic Virus Integration Site 1 Protein Homolog, EVI-1, MECOM) (MaxLight 650)
Sign In for Pricing
View Details 
MBS6222074-02 5x 0.1 mL
EVI1 (MDS1 and EVI1 Complex Locus Protein EVI1, Ecotropic Virus Integration Site 1 Protein Homolog, EVI-1, MECOM) (MaxLight 650)
Sign In for Pricing
View Details